← Leaderboards
David William Martin
Avidbiotics Corporation
$3,596,583
Attributed
$3,596,583
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2006–13$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$3,596,583 · 6
By mechanism
R43$2,523,163 · 5
R44$1,073,420 · 1
Top collaborators
No co-investigators on record.
Most similar at Avidbiotics Corporation
Same institution · by research overlap
- Dean M Scholl$3,224,757
Others in their field
Top investigators on “Pathogen”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$343,790,695
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
- Jeffrey P Krischer · University Of South Florida$130,496,919
- Mark S Klempner · Tufts Medical Center$128,021,180
- Timothy Stedman · American Type Culture Collection$122,230,581
- Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai$99,962,183
Research focus
PathogenBacteriaEngineeringKillingsBactericideAntibioticsIn VitroProteinsInfectionPublic Health RelevancePneumoniaParticlePharmacodynamicsAnimal ModelNosocomial InfectionsPreventIn VivoBinding (Molecular Function)Antibiotic ResistanceEscherichia ColiAntibodiesDoseDrug KineticsGenes
Grant awards (10)
DIVERSIFYING MICA TO CREATE TARGETED ADAPTERS TO RECRUIT AND ACTIVATE NK CELLS TO$316,078
R43 · FY2013 · TR · contact PI
TARGETABLE BACTERICIDAL PROTEINS TO SPECIFICALLY KILL CLOSTRIDIUM DIFFICILE BACTE$300,000
R43 · FY2013 · AI · contact PI
TARGETABLE BACTERICIDAL PROTEINS TO SPECIFICALLY KILL CLOSTRIDIUM DIFFICILE BACTE$300,000
R43 · FY2012 · AI · contact PI
Targeted soluble MICA molecules to recruit innate immunity cells to kill specific$300,000
R43 · FY2011 · AI · contact PI
Create, evaluate and develop pre-clinically an engineered R-type pyocin to specif$228,071
R43 · FY2011 · AI · contact PI
Non-clinical Development of Bactericidal Proteins Targeting Plague$470,775
R44 · FY2010 · AI · contact PI
Targeted soluble MICA molecules to recruit innate immunity cells to kill specific$300,000
R43 · FY2010 · AI · contact PI
Create, evaluate and develop pre-clinically an engineered R-type pyocin to specif$284,032
R43 · FY2010 · AI · contact PI
Non-clinical Development of Bactericidal Proteins Targeting Plague$602,645
R44 · FY2009 · AI · contact PI
HOST RANGE DIVERSITY OF BACTERIOPHAGE FOR Y. PESTIS$494,982
R43 · FY2006 · AI · contact PI